title: Effects of prostaglandin E1 in twelve-hour lung preservation.
abstract: The effects of hypothermic lung preservation were evaluated in 12 mongrel dogs receiving double lung allografts. Animals underwent transplant procedures after 12 hours of static preservation at 4 degrees C following pulmonary artery flush with 60 to 80 ml/kg cold modified Collins solution. Donors were pretreated with allopurinol and recipients with methylprednisolone and perireperfusion deferoxamine. Six donor animals received a PGE1 infusion (20 to 500 ng/kg/min) for 20 minutes before harvest at doses causing a significant reduction in pulmonary vascular resistance. After implantation, recipients were maintained at ventilator settings identical to those used in donors. A fixed FIO2 (0.4) was maintained, except for 15-minute periods of FIO2 1.0 that were used to measure left-to-right intrapulmonary shunt fraction (Qs/Qt) and alveolar-arterial oxygen gradients (PAO2-PaO2). Cardiopulmonary function was studied for 20 hours. Pretreatment with PGE1 resulted in reduced survival (p less than 0.05) and increased PAO2-PaO2 (p less than 0.05) and Qs/Qt (p less than 0.05) 30 minutes after reperfusion. After 60 minutes of reperfusion, mean arterial pO2 (FIO2 0.4) was 148 mm Hg in controls and 80.5 mm Hg in the PGE1 group (p less than 0.02). There was no significant difference in pulmonary vascular resistance, cardiac output, mixed venous oxygen saturation, airway resistance, compliance and physiologic dead space between groups at any time after implantation. After 20 hours of reperfusion, pO2 (FIO2 0.4) in the control group was well maintained at 140 (+/- 52) mm Hg. The method of lung preservation in control animals resulted in good survival and adequate gas exchange after 12 hours of ischemia and 20 hours of reperfusion.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Division of Thoracic and Cardiovascular Surgery, University of California, San Diego Medical Center.
authors.forename: R S
authors.initials: RS
authors.lastname: Bonser
authors.forename: L S
authors.initials: LS
authors.lastname: Fragomeni
authors.forename: S W
authors.initials: SW
authors.lastname: Jamieson
authors.forename: R J
authors.initials: RJ
authors.lastname: Fischel
authors.forename: K M
authors.initials: KM
authors.lastname: Harris
authors.forename: B J
authors.initials: BJ
authors.lastname: Edwards
authors.forename: D
authors.initials: D
authors.lastname: Rotenberg
authors.forename: M P
authors.initials: MP
authors.lastname: Kaye
mesh_terms: D000527:Alprostadil / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D004285:Dogs; D007261:Infusions, Intra-Arterial; D008168:Lung; D016040:Lung Transplantation / Q000502:physiology*; D009926:Organ Preservation; D011651:Pulmonary Artery; D011652:Pulmonary Circulation / Q000502:physiology; D011659:Pulmonary Gas Exchange / Q000502:physiology; D015656:Respiratory Mechanics / Q000502:physiology; D013997:Time Factors; D014019:Tissue Donors
chemical_list: D000527:Alprostadil